Physician profile
Stephen G Portera
NPI 1205803608
$2,817.37
in general payments reported to CMS, 2019-2025
20 companies · $361 in 2025
The $361 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $681 · 2020: $335 · 2021: $636 · 2022: $414 · 2023: $272 · 2024: $119 · 2025: $361.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $752.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $751.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $1,392.89 | 2019-2024 | Myrbetriq, Veozah |
| Sumitomo Pharma America, INC. | $270.96 | 2023-2025 | Gemtesa |
| Pfizer INC. | $234.09 | 2019-2024 | |
| Abbvie INC. | $129.35 | 2019-2024 | |
| Duchesnay USA Incorporated | $93.25 | 2019 | |
| Caldera Medical, INC | $91.19 | 2021 | |
| Amag Pharmaceuticals, INC. | $86.51 | 2019 | |
| Allergan, INC. | $70.12 | 2019-2022 | |
| Boston Scientific Corporation | $68.21 | 2022-2025 | Axonics |
| Bard Peripheral Vascular, INC. | $62.83 | 2019 | |
| Millicent US INC | $58.24 | 2021-2025 | Intrarosa, Femring |
| Urovant Sciences INC | $51.00 | 2022 | |
| Coloplast Corp | $50.32 | 2020-2025 | |
| Medtronic, INC. | $28.23 | 2023 | Truclear |
| Provepharm INC. | $27.91 | 2025 | Bludigo |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Therapeuticsmd, INC. | $26.27 | 2019 | |
| Convatec INC. | $25.85 | 2025 | |
| Axonics, INC. | $21.40 | 2021 | |
| Rochester Medical Corporation | $18.42 | 2019 | |
| Allegis Pharmaceuticals, LLC | $10.33 | 2023 | Urimar-T Caps |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Portera listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.